Skip to main content
padlock icon - secure page this page is secure

Open Access Dendritic Cell-Based Immune Therapy in Liver Diseases

Download Article:
(PDF 199.2 kb)
The field of immune therapy is currently undergoing a shift in focus, from non antigen-specific immune modulator-based immune therapy to antigen-based vaccine therapy to more sophisticated cell-based vaccine applications. Dendritic cells (DCs) are rare leukocytes that are uniquely potent in their ability to capture, process and present antigens to T cells. By culturing DCs with viral antigens or tumor-associated antigens or different cellular products, immunogenic or tolerogenic DCs can be produced. When antigen-pulsed DCs are administered, an increase in the functional capacities of cells of innate immune system is observed. Also, patients administered with antigen-loaded DCs exhibit an augmentation of helper T cells, cytotoxic T cells, and plasma cells activities. Patients with liver diseases exhibit distorted immune responses to invading pathogens or cancer cells or autoantigens. On the other hand, recovery from liver diseases is usually associated with restoration of host immunity. In this review, we would discuss about rationale and strategies of immune therapy including DC-based therapy in liver diseases.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Antigen-pulsed dendritic cells; Chronic liver diseases; DC-based therapy; antigen-based vaccine therapy; antigen-specific immunity; dendritic cells; immune therapy; liver diseases; modulator-based immune therapy; non antigen-specific immunity

Document Type: Research Article

Publication date: February 1, 2012

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more